Our website uses cookies in order to enhance your browsing experience. Refer to our privacy policy for more details. Please note that by using this site, you are consenting to the use of cookies. Internet Explorer is not supported. www.chugai-pharmabody.com works best on Chrome, Firefox, Edge and Safari.

Chugai Group | Contact Us | Sitemap
Contact

Science and Technology

We discover potential drugs by combining our top-level antibody engineering and cyclic peptide technologies with a comprehension of biological mechanisms to solve unmet medical needs against disease.

Antibody Engineering Technology

Recycling Antibody®

Allows a single antibody molecule to bind to an antigen multiple times while conventional antibodies bind only once. Applied to the FDA-approved product, satralizumab.
More >

Sweeping Antibody®

The Sweeping Antibody® is a recycling antibody engineered further to bind to FcRn at neutral pH.
More >

Bispecific Antibody

A bispecific antibody that binds to two different antigens with its antigen-binding sites.
More >

T-Cell Redirecting Antibody

T-Cell Redirecting Antibodies (TRAB) target various tumor antigens.
More >

Switch Antibody™

Switch-Ig™ is an antibody that specifically binds to the target antigens in the tumor microenvironment.
More >

Cyclic Peptide

Allows targeting intracellular protein-protein interactions via oral administration.
More >